
|Articles|October 1, 2005
- Volume 0 0
Drug Chains Urge National OTC Drug Rules
Author(s)Ken Rankin
Advertisement
A flurry of new and conflicting stateand local laws regulating the sale ofOTC cold products containing pseudoephedrineis creating complianceproblems for drug chains operating inmultiple jurisdictions.
Chain drugstore leaders urged Congressto adopt a national standard forthe sale of OTC cold drugs. They warnedthat a "patchwork" system of differingstate and local restrictions on the sale ofthese drugs will actually play into thehands of criminals seeking source materialfor illegal methamphetamine.
Mr. Rankin is a freelance medical writer.
Articles in this issue
over 20 years ago
A Pharmacist's Guide to OTC Therapy: Ocular Care Productsover 20 years ago
Dangerous Liaisons: Schizophrenia and Diabetesover 20 years ago
Tarceva Extends Lung Cancer Survivalover 20 years ago
Inhaled Morphine Aids Cancer-related Dyspneaover 20 years ago
Diuretic Best BP Therapy for African Americansover 20 years ago
A Pharmacist's Guide to OTC Therapy: Diabetic Foot Care Productsover 20 years ago
New Drug Blocks Out AIDS Virusover 20 years ago
Viagra Ingredient Has Another Useover 20 years ago
GUEST COMMENTARY: FIGHTING THE NEW PHARMACOPHOBIAAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Factors Associated With GLP-1 RA Nonresponse in T2D—and What Pharmacists Should Screen For
2
ADA 2026: Survodutide Cuts Visceral Fat and Normalizes Liver Fat in MASLD. Here's What the Data Mean for Metabolic Risk
3
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis, Expert Says
4
The Hidden Reimbursement Crisis in Medicare’s Drug Price Negotiation Program
5






































































































































